OCI

NEW YORK (GenomeWeb News) – Canada's Princess Margaret Cancer Foundation said today that it will use a new C$50 million (US$50.3 million) private donation to fund a research effort that will use genomics, molecular imaging, and tumor biology studies to develop personalized cancer medicine innovat

This story has been updated to include additional information from a US survey on people's attitudes about cost of genetic testing. Originally published June 4.

Two Ontario cancer institutes will use the support to seek biomarkers for colorectal cancer.

Founded in 2000 on technology developed at the Ontario Cancer Institute and University of Toronto, Molecular Templates had difficulty securing add-on funding in its home country following a $1.5 million investment earlier this decade.

Australia's National Health and Medical Research Council has awarded the University of Queensland about US$19.3 million to support it's cancer genome sequencing project aimed at characterizing pancreatic and ovarian cancers.

A team of Ontario researchers has identified a six-gene signature that can help predict non-small cell lung cancer outcomes — and uncovered evidence that there may be thousands of alternative prognostic signatures for the disease.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.